Min Cui

Min Cui, PhD, is the Founder and Managing Director of Decheng Capital. He is a member of the Board of Directors of AccuraGen, Ariagen, ARMO BioSciences, CardioMed, EpimAb Biotherapeutics, GenapSys, GeneMDx, Ketai Medical, Levitas and SINOMED. Prior to founding Decheng Capital, Min was an investment partner at Bay City Capital and director of Strategic Investment for the Southern Research Institute. Min co-founded Pan Pacific Pharmaceuticals and Hucon Biopharmaceuticals. Min holds a PhD in Cancer Biology from Stanford University and BS and MS degrees in Molecular Biology from Peking University. Min was also a Co-Founder of CNetwork, a San Francisco-based non-profit organization dedicated to serving Chinese communities in North America.

Min Cui is the Founder and Managing Director at Decheng Capital, based in United States, North America. With a background in Financial Services, Min Cui has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.